Abstract
A patient with Parkinson's disease, in whom polycythemia vera was known to be present for several years prior to the onset of parkinsonian symptoms, received treatment with a preparation consisting of L‐dopa plus a decarboxylase inhibitor (Madopar). Improvement in the parkinsonian symptoms was associated with marked improvement in the polycythemia. A therapeutic trial of the same L‐dopa preparation in 2 other patients with polycythemia had similar effects. The cases are presented and the possible central therapeutic effect of L‐dopa is discussed.
Original language | English |
---|---|
Pages (from-to) | 218-219 |
Number of pages | 2 |
Journal | Journal of the American Geriatrics Society |
Volume | 25 |
Issue number | 5 |
DOIs | |
State | Published - 1 Jan 1977 |
Externally published | Yes |
ASJC Scopus subject areas
- Geriatrics and Gerontology